comparemela.com

Latest Breaking News On - தொழில் தரநிலை ஆராய்ச்சி - Page 4 : comparemela.com

COVID-19s Impact On Outsourced Manufacturing

COVID-19 s Impact On Outsourced Manufacturing By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports Over the past year, COVID-19 has impacted just about every aspect of our personal and professional lives. The pharmaceutical industry rose to myriad challenges brought on by the global pandemic. One of the high points has been the development, testing, and approval of multiple coronavirus vaccines in record time. The immediate and unpredicted need for billions of doses of a vaccine sent tidal waves through the biopharma industry, derailed strategic plans set in place years ago, and forced pharmaceutical companies to shift resources.

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories News provided by Share this article Share this article SHANGHAI, Feb. 24, 2021 /PRNewswire/  WuXi Biologics ( WuXi Bio ) (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to receive this distinction in all six award categories – capabilities, compatibility, expertise, quality, reliability, and service – and across the three respondent groups - Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma). Based on research from Industry Standard Research s Contract Manufacturing Quality Benchmarking annual online surveys, more than 70 contract manufacturing organizations were evaluated on more than 23 different performance metrics. Research participants were recruited from Pharma and Biopharma companies of all

02 17 21 -- Why Did Veeva Become A Public Benefit Corporation?

02.17.21 Why Did Veeva Become A Public Benefit Corporation?     With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!   By Ed Miseta, chief editor, Clinical Leader On February 1, 2021, Veeva Systems officially became a Public Benefit Corporation (PBC). With this move, it becomes the first technology company supporting life sciences to transition to a PBC and it is also the first publicly traded corporation in any industry to make that move. How will the designation benefit the company?

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.